Tensor Ventures

QurieGen is a biotechnology company that accelerates drug discovery and development.

Edmund is an enterprise level system that interconnects all manufacturing technologies, providing a comprehensive view of entire factory.

Openvibe is a software platform focused on the design, testing, and application of Brain-Computer Interfaces (BCIs). Developed by INRIA, it enables users to interact with computers through brain activity, making it applicable in fields such as neuroscience, rehabilitation, and entertainment. This innovative approach serves various stakeholders by facilitating research and practical applications in understanding and harnessing brain signals.

Wultra specializes in providing post-quantum authentication solutions tailored for financial institutions, focusing on secure and user-friendly access to digital services. The company offers innovative, developer-friendly technology that employs NIST-endorsed quantum-resistant cryptography to enhance security and deliver a passwordless user experience. Wultra's solutions can be deployed quickly, typically within eight weeks, and are designed to comply with global regulations such as PSD3/PSR1 and eIDAS 2.0. In addition to robust security features, the company's open-source transaction signing technology enables banks and fintech companies to protect their internet and mobile applications from malware attacks and evolving cyber threats, ensuring comprehensive data protection.

DYNANIC is an IT firm that provides custom development, consulting, and training for programmable logic and its verification.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

HeartBeat.bio is a privately funded drug discovery company that specializes in developing a high-throughput three-dimensional screening platform aimed at addressing heart failure and cardiomyopathies. The company creates induced pluripotent stem cell (iPSC)-derived, multi-cellular, and lineage-controlled cardiac tissue models from healthy donors and patients. These advanced cardiac organoids closely mimic human heart physiology, allowing healthcare professionals to significantly enhance the drug discovery process for cardiovascular treatments. By utilizing this innovative approach, HeartBeat.bio seeks to improve success rates in clinical trials while also minimizing the time and costs associated with the development of new therapeutic compounds.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

Blockmate is a developer of an open-crypto API platform that connects users' cryptocurrency data to applications. The company offers a unified API that delivers premium insights into aggregated financial views from various global cryptocurrency accounts. This includes detailed information on risk and credit scoring, as well as support for regulatory compliance. Additionally, Blockmate Link is a fast and efficient application that can be installed in minutes, enhancing the accessibility and utility of the platform for users seeking comprehensive financial insights.

Quantagonia specializes in enhancing global operations through its Decision AI and advanced quantum algorithm platform. The company focuses on helping businesses in logistics, production, and workforce management tackle complex scheduling and routing challenges with adaptive, real-time artificial intelligence that is accessible to all users. Additionally, Quantagonia provides translation tools that enable existing program codes to be compatible with quantum computers. This capability allows businesses to achieve performance improvements on classical hardware while also benefiting from enhanced efficiencies when employing quantum computing, thereby addressing intricate and time-sensitive problems that traditional methods struggle to solve.

Aireen is a medical technology company that specializes in non-invasive screening for chronic diseases through the analysis of retinal images. Utilizing artificial intelligence, Aireen's devices detect conditions such as diabetes by examining digital images of the retina. This approach allows for a painless and efficient screening process, significantly reducing both the time and cost typically associated with traditional diagnostic methods. By focusing on eye health, Aireen aims to improve access to early detection and management of chronic diseases, ultimately enhancing patient outcomes.

Contember is a developer of an enterprise application platform that facilitates the rapid and straightforward creation of custom web applications. Its AI-assisted Contember Studio allows users to conceptualize and generate functioning applications, such as internal apps, content management systems, or customer portals, in just a few minutes. The platform incorporates a pre-packed library of components and a user-friendly drag-and-drop interface, which simplifies the development process. Built on the open-source Contember framework, the final applications can be easily customized through declarative code. This framework is already in use across over 300 projects, demonstrating its effectiveness and popularity among developers.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Stacktape is a cloud development framework designed to enhance developer productivity by simplifying the deployment of applications to a production-grade infrastructure on AWS. It enables developers to deploy applications with minimal configuration, reducing the time to market from several months to just a few days. The platform offers zero-configuration source code building, auditable deployment services, domain and certificate management, and robust community support. By streamlining the deployment process, Stacktape allows companies to significantly cut costs associated with DevOps and cloud expertise, achieving savings of 90-95%. This combination of power and ease of use positions Stacktape as a valuable tool for developers seeking to deploy production-ready applications efficiently.

Anari AI develops tools for data analysis and decision-making. The tools enable users to process and interpret data. They provide insights that assist in various operational tasks. Anari AI serves sectors such as finance, healthcare, and logistics.

Tatum Limited is a blockchain development platform established in 2018 and headquartered in London, United Kingdom. The company focuses on providing developers with a user-friendly application programming interface (API) that facilitates the integration of blockchain technology into their applications. By streamlining access to advanced blockchain infrastructure, Tatum enables developers to build and deploy blockchain-based solutions quickly and efficiently. Its platform is designed to simplify the complexities of blockchain development, making it accessible for a wide range of software projects.

Solvemed Group focuses on improving neurological care, particularly in the realm of neurodegenerative diseases such as Parkinson's disease. The company utilizes proprietary machine learning technology to create innovative diagnostic-predictive digital biomarkers, which facilitate accurate and early diagnosis and monitoring for patients. By addressing the significant shortcomings in current diagnostic standards, Solvemed aims to enhance treatment outcomes and optimize healthcare systems. Their work not only assists in providing reliable diagnostics but also plays a crucial role in revolutionizing drug discovery, enabling the development of disease-modifying therapies. Collaborating with leading research institutions, Solvemed's team of scientists and technology experts strives to advance clinical trial efficiency and ultimately improve quality of care for neurological patients.

Bioo is a biotechnology company focused on generating electricity from natural processes, particularly through the decomposition of organic matter released by plants. Established in 2015, the company has developed proprietary technologies and holds patents related to its innovative methods, including electricity generation via photosynthesis. Bioo's product line targets the agricultural industry, with its flagship offerings designed to integrate sustainable energy solutions into farming practices. The company has received recognition for its innovation, including support from the European Union and various private sector partners in energy, biotechnology, and finance. Bioo has garnered over 50 international awards and has been featured in prominent media outlets, such as Forbes and CNBC, establishing its reputation as a leader in the field of sustainable energy.

QC82 is focused on advancing photonic quantum computing through the development of innovative room-temperature photonic chips. The company's co-founders have made significant strides in quantum technologies, including the establishment of cluster-state entanglement for continuous variable quantum computing and the manufacture of quantum photonic circuits featuring 40 entangled modes. Additionally, QC82 has created low-noise single-photon detectors optimized for telecom wavelengths. By integrating error correction and fault tolerance into their photonic chips, QC82 aims to provide scalable solutions that enhance practical applications of quantum computing, ultimately resolving critical challenges in the field.

Veracity Protocol operates an innovative platform that utilizes Vision AI to identify, authenticate, and track physical objects. By employing smartphones, the company generates non-invasive codes based on the unique material structure of items, ensuring secure identification without the need for physical labels or tags. Its services encompass product identification, high-accuracy authentication to prevent counterfeiting, and microstructure-level inspection for integrity monitoring. Additionally, Veracity Protocol facilitates tokenization, creating immutable links between physical products and blockchain records to enhance ownership assurance and authenticity verification. The platform aims to provide a scalable and cost-effective solution for clients seeking automated visual inspections and quality assurance for their assets.

Pointee is a developer of a process analytics platform focused on enhancing robotic process automation (RPA) by tracking and improving operational workflows. By leveraging artificial intelligence and data science, the platform automatically analyzes resource utilization at each step of a process, identifying critical areas for improvement. This capability allows businesses to save significant costs on individual processes while facilitating the rapid and effective scaling of their RPA efforts. Pointee's insights enable organizations to elevate performance and optimize their intelligent automation operations.

Blockmate is a developer of an open-crypto API platform that connects users' cryptocurrency data to applications. The company offers a unified API that delivers premium insights into aggregated financial views from various global cryptocurrency accounts. This includes detailed information on risk and credit scoring, as well as support for regulatory compliance. Additionally, Blockmate Link is a fast and efficient application that can be installed in minutes, enhancing the accessibility and utility of the platform for users seeking comprehensive financial insights.

Superface is an innovative workflow automation platform that empowers non-technical users to automate tasks requiring human judgment, enhancing productivity and organizational efficiency. By leveraging advanced AI and integration capabilities, Superface offers a unique approach to connecting Application Programming Interfaces (APIs). Its open-source library facilitates seamless connections between applications and external platforms, allowing developers to autonomously create, retrieve, and manage data. This capability positions Superface as a disruptive force in the business automation landscape, paving the way for greater autonomy in software integration.

UltimateSuite is a company focused on enhancing organizational efficiency through automation and workforce intelligence. It offers a task mining platform that automates business process analysis, enabling firms to analyze internal processes and tasks effectively. By leveraging its expertise in automation and innovation, UltimateSuite helps businesses improve operational efficiencies and implement strategies that yield proven returns on investment.

OP Games provides tools that empower game developers to create games with integrated crypto rewards. The company focuses on enabling developers and the gaming community to collectively own, manage, and monetize gaming experiences. Its offerings include mini esports experiences, such as tournaments, duels, and arcades, where players can use cryptocurrencies for buy-ins and payouts. This approach not only enhances gameplay but also transforms games into competitive multiplayer environments, allowing developers to leverage new monetization strategies.

Neuronix AI Labs specializes in artificial intelligence-based solutions for computer vision, aiming to reduce costs and power consumption for devices with limited computational resources. Founded by Yaron Raz and Asher Hazanchuk and headquartered in Sunnyvale, California, the company develops software licenses and core intellectual property that can be integrated into next-generation silicon or executed on existing programmable hardware. Neuronix AI Labs focuses on practical applications in industries such as industrial automation, smart cities, and military operations, enabling clients to efficiently run computer-vision applications even in environments with constrained computing, memory, or battery capabilities. The company has established a strategic partnership with AMD to enhance its offerings.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Aireen is a medical technology company that specializes in non-invasive screening for chronic diseases through the analysis of retinal images. Utilizing artificial intelligence, Aireen's devices detect conditions such as diabetes by examining digital images of the retina. This approach allows for a painless and efficient screening process, significantly reducing both the time and cost typically associated with traditional diagnostic methods. By focusing on eye health, Aireen aims to improve access to early detection and management of chronic diseases, ultimately enhancing patient outcomes.

Veracity Protocol operates an innovative platform that utilizes Vision AI to identify, authenticate, and track physical objects. By employing smartphones, the company generates non-invasive codes based on the unique material structure of items, ensuring secure identification without the need for physical labels or tags. Its services encompass product identification, high-accuracy authentication to prevent counterfeiting, and microstructure-level inspection for integrity monitoring. Additionally, Veracity Protocol facilitates tokenization, creating immutable links between physical products and blockchain records to enhance ownership assurance and authenticity verification. The platform aims to provide a scalable and cost-effective solution for clients seeking automated visual inspections and quality assurance for their assets.

Superface is an innovative workflow automation platform that empowers non-technical users to automate tasks requiring human judgment, enhancing productivity and organizational efficiency. By leveraging advanced AI and integration capabilities, Superface offers a unique approach to connecting Application Programming Interfaces (APIs). Its open-source library facilitates seamless connections between applications and external platforms, allowing developers to autonomously create, retrieve, and manage data. This capability positions Superface as a disruptive force in the business automation landscape, paving the way for greater autonomy in software integration.

Tatum Limited is a blockchain development platform established in 2018 and headquartered in London, United Kingdom. The company focuses on providing developers with a user-friendly application programming interface (API) that facilitates the integration of blockchain technology into their applications. By streamlining access to advanced blockchain infrastructure, Tatum enables developers to build and deploy blockchain-based solutions quickly and efficiently. Its platform is designed to simplify the complexities of blockchain development, making it accessible for a wide range of software projects.